Paige Twenter

Chicago

Assistant Editor and Reporter at Becker's Hospital Review

Assistant editor + reporter at @BeckersHR / she her hers / houseplant enthusiast

Featured in: Favicon

beckershospitalreview.com Favicon

newsbreak.com Favicon

metroparent.com Favicon

chicagoparent.com Favicon

loyolaphoenix.com Favicon

conservativeangle.com Favicon

themillennialpress.com Favicon

beckersbehavioralhealth.com Favicon

bizlim.com Favicon

beckersasc.com + 2 more

Articles

Eli Lilly 1st oral small-molecule GLP-1 caps late-stage trial

1 week ago | beckershospitalreview.com | Alexandra Murphy |Paige Twenter |Erica Carbajal

Eli Lilly completed a phase 3 trial for its weight loss drug, orforglipron, which showed promising results in evaluating its safety and efficacy for adults with Type 2 diabetes and inadequate glycemic control. The once-daily oral GLP-1 receptor agonist significantly reduced blood sugar and body weight in adults with Type 2 diabetes and had a safety profile consistent with injectable therapies, according to an April 17 news release from the drugmaker.
What drives tech success in hospitals?

1 week ago | beckershospitalreview.com | Naomi Diaz |Mackenzie Bean |Paige Twenter

Sixty-one percent of health system leaders say C-suite alignment and collaboration is the top driver of successful technology initiatives, according to an April 17 survey from the Deloitte Center for Health Solutions and the Scottsdale Institute. The survey gathered responses from 43 executive leaders—including CEOs, technology executives and functional leaders—from U.S.-based health systems between December 2024 and January 2025.
Harvard's medical research takes hit in federal funding freeze: 6 things to know - Becker's Hospital Review

1 week ago | beckershospitalreview.com | Erica Carbajal |Alexandra Murphy |Paige Twenter |Kelly Gooch

The effects of the Trump administration’s decision to freeze more than $2.2 billion in federal funding to Cambridge, Mass.-based Harvard University are coming into sharper focus, as researchers begin to receive stop work orders for multimillion-dollar projects. On April 14, federal officials said they would freeze $2.2 billion in multiyear grants along with a $60 million contract to the school as part of an investigation into the university’s handling of antisemetic harassment on its campus.
FDA OKs 1st trial to test gene-edited pig livers for treating liver failure

1 week ago | beckershospitalreview.com | Alexandra Murphy |Paige Twenter |Kelly Gooch |Kristin Kuchno

The FDA has cleared the first clinical trial to test genetically engineered pig livers in patients who have acute-on-chronic liver failure. The trial will evaluate the use of a Egenesis porcine liver genetically modified to be more compatible with the human immune system in combination with the OrganOx extracorporeal liver cross-circulation system, according to an April 15 Egenesis news release.
Mark Cuban’s drug firm targets injectable shortages

1 week ago | beckershospitalreview.com | Paige Twenter |Alexandra Murphy |Kelly Gooch |Kristin Kuchno

Mark Cuban’s latest move to disrupt the pharmaceutical supply chain is expanding — this time, tackling the injectable drug market through a new partnership with distributor Morris & Dickson. His company, Mark Cuban Cost Plus Drug Co., is partnering with Morris & Dickson, a full-line and specialty pharmaceutical distributor, to improve access to injectables nationwide.
From pilot to priority: The rise of ambient AI scribes in healthcare

1 week ago | beckershospitalreview.com | Naomi Diaz |Paige Twenter |Mackenzie Bean |Giles Bruce

When ambient AI scribes first emerged in healthcare, they were viewed as niche tools — cutting-edge, yes, but not quite ready for widespread use. Today, ambient documentation has evolved from a proof of concept to a top IT priority across nearly all U.S. health systems. The promise is straightforward: free clinicians from the keyboard by using AI-powered tools that listen, transcribe and structure patient conversations.
Trump targets drug prices with new executive order: 5 things to know

1 week ago | beckershospitalreview.com | Alexandra Murphy |Paige Twenter |Mackenzie Bean

President Donald Trump signed an executive order aimed at lowering drug prices and expanding access to affordable medications, according to an April 15 White House Fact Sheet. Through the efforts laid out in the order, the Trump administration said it aims to surpass the 22% in savings that the Biden administration achieved during the first year of the Medicare Drug Pricing Negotiation Program. Here are five things to know:The order directs HHS secretary Robert F.
M Health Fairview revises maternal health screenings to eliminate biases

1 week ago | beckershospitalreview.com | Paige Twenter |Mackenzie Bean |Mariah (Handy) Taylor

Minneapolis-based M Health Fairview is improving culturally appropriate care and changing maternal screening practices in its commitment to health equity, according to an April 15 news release. In late 2023, the health system launched the Birth Justice Initiative to eliminate racial bias in maternal healthcare and improve patient outcomes. The group quickly discovered a gap in prenatal care.
After pharmacist walkout, Alabama passes PBM regulation law

1 week ago | beckershospitalreview.com | Paige Twenter |Mackenzie Bean |Mariah (Handy) Taylor

Alabama Gov. Kay Ivey signed the Community Pharmacy Relief Act into law April 15, a measure supported by pharmacy employees who staged a walkout at more than 100 pharmacies across the state. The legislation prohibits pharmacy benefit managers from steering patients to a mail-order pharmacy or PBM affiliate, reimbursing a pharmacy less than what it reimburses an affiliate, practice spread pricing and charging pharmacies point-of-sale or retroactive fees for claims that have already been paid.
Leapfrog creates new resource for hospitals caring for high share of low-income patients - Becker's Hospital Review | Healthcare News & Analysis

1 week ago | beckershospitalreview.com | Erica Carbajal |Mariah (Handy) Taylor |Madeline Ashley |Paige Twenter

The Leapfrog Group has created a learning collaborative program to provide resources and guidance to hospitals that serve a disproportionately high share of low-income and uninsured patients. Four notes: The program is part of Leapfrog’s Judie Burrows Education Institute and is free to participating hospitals. It is supported by the AARP and other corporate contributions.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Coverage map

X (formerly Twitter)

Followers: 183
Tweets: 187
DMs Open: No

Paige Twenter @paige_twenter

7 Apr 23

RT @foxerinr: 👇 https://t.co/8ffAk3STa0

Paige Twenter @paige_twenter

27 Sep 22

Because of “overwhelming demand” from its 1 million+ customers, Mark Cuban’s pharmacy won’t make its own PBM —> https://t.co/YUxPOOSt7k @BeckersHR @costplusdrugs

Paige Twenter @paige_twenter

8 Aug 22

RT @GilesBruce: .@paige_twenter and I wrote about drones for @BeckersHR, feat. @fencl_amber of @NovantHealth, @Intermountain, @cardinalheal…